Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy.

The association between HIV infection, antiretroviral therapy and cervical squamous intraepithelial lesions in South Western Nigerian women. PLoS One (2014) 0.83

Structural and sociocultural factors associated with cervical cancer screening among HIV-infected African American women in Alabama. AIDS Patient Care STDS (2015) 0.77

Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population. PLoS One (2016) 0.76

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86

The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA (2002) 15.59

Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med (1998) 11.61

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst (2005) 5.29

Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81

Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA (2000) 2.80

Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51

Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev (1997) 2.36

Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis (2003) 1.91

Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res (2004) 1.90

New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst (1995) 1.71

The viral etiology of cervical cancer. Virus Res (2002) 1.67

1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. MMWR Recomm Rep (1997) 1.66

HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer (2006) 1.54

Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet Gynecol (2000) 1.53

Statistical analysis of case-control studies. Epidemiol Rev (1994) 1.49

Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol (2008) 1.35

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis (2001) 1.28

Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol (2007) 1.23

Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection. Diagn Mol Pathol (2005) 1.04

Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. BJOG (2004) 1.01

Prevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma. Infect Agent Cancer (2008) 1.00

A longitudinal study of HPV detection and cervical pathology in HIV infected women. Sex Transm Infect (2000) 1.00

Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women. Cytopathology (2001) 0.87

Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women. AIDS (2003) 0.86

Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection -- review. Mem Inst Oswaldo Cruz (2005) 0.79

[Precancerous lesions of the uterine cervix in Pointe-Noire, Congo]. Med Trop (Mars) (2007) 0.78

[Screening of infectious microorganisms in blood banks in Douala (1995-2004)]. Sante (2009) 0.88